{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T11:51:05Z","timestamp":1765885865950,"version":"3.44.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Basel Cardiovascular Research Foundation, Basel"},{"name":"Swiss National Foundation for Research, Berne"},{"name":"Swiss Heart Foundation, Berne, Switzerland"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.ijcard.2013.01.257","type":"journal-article","created":{"date-parts":[[2013,2,27]],"date-time":"2013-02-27T12:31:05Z","timestamp":1361968265000},"page":"2381-2388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease"],"prefix":"10.1016","volume":"168","author":[{"given":"Maria","family":"Wanitschek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Pfisterer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Hvelplund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"De Servi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osmund","family":"Bertel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raban","family":"Jeger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Rickenbacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan","family":"Iversen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan Skov","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soeren","family":"Galatius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannes","family":"Alber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2013.01.257_bb0005","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2013.01.257_bb0010","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1681\/ASN.2005101085","article-title":"Chronic kidney disease and mortality risk: a systematic review","volume":"17","author":"Tonelli","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ijcard.2013.01.257_bb0015","doi-asserted-by":"crossref","first-page":"629","DOI":"10.7326\/0003-4819-134-8-200104170-00007","article-title":"Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial","volume":"134","author":"Mann","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijcard.2013.01.257_bb0020","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1046\/j.1523-1755.1999.00773.x","article-title":"Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency","volume":"56","author":"Culleton","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.ijcard.2013.01.257_bb0025","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/hrt.2003.015503","article-title":"Renal dysfunction and acceleration of coronary disease","volume":"90","author":"Yerkey","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2013.01.257_bb0030","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.amjcard.2005.10.018","article-title":"Impact of chronic renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary intervention with sirolimus-eluting stents versus bare metal stents","volume":"97","author":"Kuchulakanti","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2013.01.257_bb0035","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.amjcard.2004.08.089","article-title":"Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents","volume":"95","author":"Lemos","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2013.01.257_bb0040","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/eurheartj\/ehq277","article-title":"Guidelines on myocardial revascularization","volume":"31","author":"Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC)","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2013.01.257_bb0045","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00392-011-0347-7","article-title":"Impact of chronic kidney disease on the prognosis of patients undergoing percutaneous coronary interventions using drug-eluting stents","volume":"100","author":"Kaya","year":"2011","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.ijcard.2013.01.257_bb0050","first-page":"808","article-title":"Impact of renal insufficiency on clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents","volume":"69","author":"Nakazawa","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ijcard.2013.01.257_bb0055","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1056\/NEJMoa1009406","article-title":"Drug-eluting versus bare-metal stents in large coronary arteries","volume":"363","author":"Kaiser","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2013.01.257_bb0060","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ahj.2007.11.011","article-title":"Drug-eluting or bare-metal stents for large coronary vessel stenting? The BASKET-PROVE (PROspective Validation Examination) trial: study protocol and design","volume":"155","author":"Pfisterer","year":"2008","journal-title":"Am Heart J"},{"issue":"2 Suppl. 1","key":"10.1016\/j.ijcard.2013.01.257_bb0070","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","author":"National Kidney Foundation","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ijcard.2013.01.257_bb0075","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1056\/NEJMoa067731","article-title":"Stent thrombosis in randomized clinical trials of drug-eluting stents","volume":"356","author":"Mauri","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2013.01.257_bb0080","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2013.01.257_bb0085","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1093\/eurheartj\/ehr204","article-title":"Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology","volume":"32","author":"Steg","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2013.01.257_bb0090","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jacc.2005.09.060","article-title":"A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes","volume":"47","author":"Rao","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2013.01.257_bb0095","first-page":"1786","article-title":"Impact of mild or moderate chronic kidney disease on the frequency of restenosis: results from the PRESTO trial","volume":"44","author":"Best","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2013.01.257_bb0100","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1053\/j.ajkd.2009.01.263","article-title":"Clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents versus bare-metal stents in hemodialysis patients","volume":"54","author":"Yachi","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ijcard.2013.01.257_bb0105","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jacc.2012.04.017","article-title":"Prognostic utility of neutrophil gelatinase-associated lipocalin (NGAL) in predicting mortality and cardiovascular events in patients with ST-element elevation myocardial infarction treated with primary percutaneous coronary intervention","volume":"60","author":"Lindberg","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2013.01.257_bb0110","doi-asserted-by":"crossref","unstructured":"Franczyk-Sk\u00f3ra B, Gluba A, Banach M, Koz\u0142owski D, Ma\u0142yszko J, Rysz J. Prevention of sudden cardiac death in patients with chronic kidney disease. BMC Nephrol 2012;3(13):162.","DOI":"10.1186\/1471-2369-13-162"},{"key":"10.1016\/j.ijcard.2013.01.257_bb0115","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.amjcard.2007.11.009","article-title":"Impact of renal insufficiency on angiographic, procedural, and in-hospital outcomes following percutaneous coronary intervention","volume":"101","author":"Osten","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2013.01.257_bb0120","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/01.CIR.0000042700.48769.59","article-title":"Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency","volume":"107","author":"Shlipak","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2013.01.257_bb0125","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.amjcard.2010.07.011","article-title":"Impact of moderate renal insufficiency on restenosis and adverse clinical events after sirolimus-eluting and bare metal stent implantation (from the SIRIUS trials)","volume":"106","author":"Garg","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2013.01.257_bb0130","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.ahj.2005.01.032","article-title":"Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: results from the TAXUS-IV Trial","volume":"150","author":"Halkin","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijcard.2013.01.257_bb0135","doi-asserted-by":"crossref","first-page":"412","DOI":"10.5414\/CNP64412","article-title":"Risk of bleeding and restenosis among chronic kidney disease patients undergoing percutaneous coronary intervention","volume":"64","author":"Attallah","year":"2005","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.ijcard.2013.01.257_bb0140","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jcin.2008.06.012","article-title":"In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry","volume":"2","author":"Latif","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ijcard.2013.01.257_bb0145","first-page":"942","article-title":"Drug-eluting stents in patients with end-stage renal disease: meta-analysis and systematic review of the literature","volume":"76","author":"Abdel-Latif","year":"2010","journal-title":"Catheter Cardiovasc Interv"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527313003173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527313003173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:38:22Z","timestamp":1759091902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527313003173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0167527313003173"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2013.01.257","relation":{},"ISSN":["0167-5273"],"issn-type":[{"type":"print","value":"0167-5273"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2013.01.257","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}